si-544

N/A

Report date: 2024/01/19 15:21:16
NME

Base Information

Drug Namesi-544
Drug Alias Namesi-544
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated potassium channel subunit Kv1.3 blockers
TargetsVoltage-gated potassium channel subunit Kv1.3
Therapy Area/IndicationsPsoriasisDermatitis, AtopicArthritis, Rheumatoid +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSelectION Inc
China Registration ClassN/A

Develop Information

Active CompaniesSelectION Inc
Inactive CompaniesN/A
Active IndicationsPsoriasisDermatitis, AtopicArthritis, Rheumatoid +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A